Dr. Said is considered to be a pioneer and an
expert in the fields of traditional Greco-Arab medicine and herbal medicine pharmacology.
Dr. Said has conducted various researches, in addition to numerous scientific publications in pharmacology, toxicology, botanical pest control abilities, organic farming and others. Dr. Said is involved in guidance of students in herbal medicine biotechnology and the connection with Heritage in science. Dr. Said is known to be an expert in understanding ancient scripts and has explored many botanical ingredients that were mentioned in ancient texts using modern science methods. In addition, Dr. Said is a respected member in various regional Arab committees dealing with health, policy and social issues. Currently, Dr. Said serves as the head of the medicinal plant project in the Galilee Society R&D regional center.Dr. Said holds a D.Sc. in pharmacology from the Technion Institute, Haifa, Israel

Dr. Fulder is an international recognized
expert in the fields of medicinal plants and indigenous medicine. Dr. Fulder holds a degree in biochemistry from Oxford University and doctorate on gerontology from
the National Institute of Medical Research in London, England.
Dr. Fulder has written11 books on herbs and alternative medicine and had published many scientific papers

Professor of cell biology and immunology at the Arab American university in Jenin, PA and acts as director of the Qasemi Research Center- Al-Qasemi Academic College. His research interests include anti-inflammatory and anticancer properties of medicinal plants. He is the author of the first academic book about Arab and Islamic herbal medicine published by John Wiley 2011. He is member of the editorial board of Evidence based Alternative and Complementary Medicine (eCAM).

Dr. Breznik has a long and impressive work  history. From 2015- 2021 he has been a  Private Business Advisor to many companies

his main activities and responsibilities  have been as an advisor to companies

related to pharmaceutical regulation, market  access, sales and marketing, and business  organizations. He has carried out work related  to organization setup and optimization with  preparation on GMP certification. In one

case, he aided in the start-up of  a company  preparing to produce cannabis extracts and  CBD. From 2002-2004 he was a Central  Product Manager for GlazoSmithKline. He  was responsible for medical and marketing  strategy for 25 markets and 5 top products  (antibiotics and antimycotics) at the time  representing 10% of company revenue.

Dr. Milanova has a successful career in management, product development, manufacturing, marketing, and regulatory  strengths with a scientific research foundation. Dr. Milanova was a manager of large interdisciplinary projects in the areas of  pharmaceuticals, such as cancer, cardiovascular, immunosuppressive medicines, anti-infectious, steroids, antibiotics as well as  nutraceuticals/ functional foods, food ingredients, natural products, and environmental technologies. At PARI Biomedical LLC  Dr. Milanova was involved in the development, manufacturing, and distribution of pharmaceutical drugs to emerging market countries in Eastern Europe, Asia and Africa. Dr. Milanova has profound knowledge of the pharmaceutical industry and business  trends in increased revenue, increased process efficiencies, increased sales, improved record keeping processes and SOP writing.

Dr. Nazim Nassar, an expert in Biological, Pharmacological, and Pharmaceutical sciences, has honed his expertise through studies at The Hebrew University of Jerusalem, The Technion, Monash University, and RMIT University. He earned his pharmacy degree from Monash University, which holds the top ranking globally in pharmacology and pharmacy, followed by a PhD in Pharmaceutical Sciences and Biophysics, specializing in advanced orally controlled drug delivery systems for biologics. As an entrepreneur, Dr. Nassar founded the pharmaceutical distribution center AUSTRALIAN INTERNATIONAL MEDICAL SUPPLIES (AIMS), later evolving into AIMS Medical Group. Currently, his focus is on research and lecturing in pharmacology and pharmaceutics, particularly in pioneering innovative methodologies for biologics delivery. Dr. Nassar has filed a PCT patent and coauthored book chapter and publications spanning pharmacological sciences, cancer biology, biophysics, and drug delivery systems.

Professor of Biochemistry, Medical School, Al-Quds University in Jerusalem
Riyad Amin is a professor of biochemistry and has 40 years of experience in clinical biochemistry. He has served as a professor of biochemistry for 22 years, took up the Fulbright Award in 1987, and spent 18 years serving as Chairman of a Biochemistry Department His research concentrates on natural products and disease management. During his career Riyad participated in three clinical trials in the United States as Sub-Investigator evaluating the safety and efficacy of various drugs for treating: Chronic Obstructive Pulmonary Disorder (COPD), Irritable Bowel Syndrome (IBS) and Hypertension.

GI. Head of Gastrointestinal Unit, RAMBAM Medical Center, Haifa, Israel and The Holly Family Hospital, Nazareth, Israel

Head of Gastrointestinal Unit, RAMBAM Medical Center, Haifa, Israel and the Holly Family Hospital, Nazareth, Israel

Professor Iyad Khamaysi currently  directs the Advanced Endoscopy Unit  for the Department of Gastroenterology  at the Rambam Health Care Campus.

Professor Khamaysi is an industry-  leading instructor within the field of  Gastroenterology. Professor Khamaysi  is a member of numerous national and  international medical societies. He also  serves as a scientific consultant for  numerous hospitals, medical centers,  and medical start-up companies.
 

 Nephrology. Head of Nephrology Dept., The Nazareth Hospital EMMS, Nazareth, Israel

Professor Zaher Armaly is a specialist in nephrology and internal medicine.

​

Yazbak has 17 years of industrial experience besides being senior researcher at The Galilee Society Regional Research & Development Center, which is affiliated with the University of Haifa. Dr. Yazbak is the founder and the CEO of Synthatex. Holds a Ph.D. in chemistry from the Technion - Israel Institute of Technology, Haifa, Israel.

Holds dual Bachelor's degrees in Computer Science and Biology, a Master's degree in Bioinformatics and Data Science.

​